Sponsored by Medtronic.

Key Findings Additional 24-month outcomes from the European cohort of the REVERSE trial suggest that CRT may prevent or sluggish the progression of disease in asymptomatic or mildly symptomatic center failure individuals. CRT reduced the need for heart failing hospitalization READ MORE